Invus US Partners LLC

LXRX

Invus US Partners LLC serves as Director at Lexicon Pharmaceuticals, Inc. (LXRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$2.82M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$2.82M

Companies Traded

LXRX

Active Period

Aug 2022

2 total trades

Most Recent

Buy LXRX

Aug 9, 2022 · $368.5K

Invus US Partners LLC's Insider Trading at Lexicon Pharmaceuticals, Inc. (LXRX)

Buys

2 · $2.82M

Sells

0 · $0.00

Total Shares Bought

1,129,990

Total Shares Sold

LXRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 9, 2022	Buy	147,390	$2.50	$368.5K	5,451,204
Aug 1, 2022	Buy	982,600	$2.50	$2.46M	5,303,814

Related Insiders

DEBBANE RAYMOND

Director

LXRXBuy · Feb 27, 2026

Invus Global Management, LLC

director, 10 percent owner:

LXRXBuy · Feb 4, 2026

Explore More Insider Trading Data

LXRX Insider Trading Activity

View all insider trades at Lexicon Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity